Magnetic resonance spectroscopy in cognitive research

被引:163
作者
Ross, AJ
Sachdev, PS
机构
[1] Prince Wales Hosp, Inst Neuropsychiat, Randwick, NSW 2031, Australia
[2] Univ New S Wales, Sch Psychiat, Kensington, NSW 2033, Australia
基金
英国医学研究理事会;
关键词
cognition; magnetic resonance spectroscopy; N-acetyl aspartate; neuropsychological tests; cognitive disorders;
D O I
10.1016/j.brainresrev.2003.11.001
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
The neurophysiological basis of cognition is relatively unexplained, with most studies reporting weak relationships between cognition and measures of brain function, such as event-related potentials, brain size and cerebral blood flow. Magnetic resonance spectroscopy (MRS) is an in vivo method used to detect neurochemicals within the brain that are relevant to certain brain processes. The most widely used methods are H-1-MRS and P-31-MRS, which detect compounds that contain hydrogen and phosphorus, respectively. Recent studies have shown that the absolute concentrations or ratios of these neurochemicals, in particular N-acetyl aspartate (NAA), which is associated with neuronal viability, correlate with performance on neuropsychological tests or other measures of cognitive function in normal subjects. Many studies in adults and children have shown a relationship between neurometabolite values and cognitive status or extent of cognitive dysfunction in various neurological and neuropsychiatric disorders. We review these studies and conclude that MRS has potential applications for the study of cognitive processes in health and disease and may be used clinically for differential diagnosis, the early detection of pathology and the examination of longitudinal change. (C) 2003 Elsevier B.V. All rights reserved.
引用
收藏
页码:83 / 102
页数:20
相关论文
共 212 条
[1]   Longitudinal decline of the neuronal marker N-acetyl aspartate in Alzheimer's disease [J].
Adalsteinsson, E ;
Sullivan, EV ;
Kleinhans, N ;
Spielman, DM ;
Pfefferbaum, A .
LANCET, 2000, 355 (9216) :1696-1697
[2]   Temporal lobe pHi and IQ:: No consistent correlation [J].
Anderson, B ;
Elgavish, GA ;
Chu, WJ ;
Simor, T ;
Martin, RC ;
Hugg, JW ;
Kuzniecky, RI .
INTELLIGENCE, 1998, 26 (02) :75-79
[3]   AIDS DEMENTIA COMPLEX - EVALUATION WITH PROTON MR SPECTROSCOPIC IMAGING [J].
BARKER, PB ;
LEE, RR ;
MCARTHUR, JC .
RADIOLOGY, 1995, 195 (01) :58-64
[4]  
Bartha R, 1997, ARCH GEN PSYCHIAT, V54, P959
[5]   Relationship among 1H-magnetic resonance spectroscopy, brain volumetry and genetic polymorphisms in humans with memory impairment [J].
Bartrés-Faz, D ;
Junqué, C ;
Clemente, IC ;
López-Alomar, A ;
Bargalló, N ;
Mercader, JM ;
Moral, P .
NEUROSCIENCE LETTERS, 2002, 327 (03) :177-180
[6]   Inhibition of N-acetylaspartate production: Implications for H-1 MRS studies in vivo [J].
Bates, TE ;
Strangward, M ;
Keelan, J ;
Davey, GP ;
Munro, PMG ;
Clark, JB .
NEUROREPORT, 1996, 7 (08) :1397-1400
[7]  
Bertolino A, 1996, AM J PSYCHIAT, V153, P1554
[8]   Specific relationship between prefrontal neuronal N-acetylaspartate and activation of the working memory cortical network in schizophrenia [J].
Bertolino, A ;
Esposito, G ;
Callicott, JH ;
Mattay, VS ;
Van Horn, JD ;
Frank, JA ;
Berman, KF ;
Weinberger, DR .
AMERICAN JOURNAL OF PSYCHIATRY, 2000, 157 (01) :26-33
[9]   Common pattern of cortical pathology in childhood-onset and adult-onset schizophrenia as identified by proton magnetic resonance spectroscopic imaging [J].
Bertolino, A ;
Kumra, S ;
Callicott, JH ;
Mattay, VS ;
Lestz, RM ;
Jacobsen, L ;
Barnett, IS ;
Duyn, JH ;
Frank, JA ;
Rapoport, JL ;
Weinberger, DR .
AMERICAN JOURNAL OF PSYCHIATRY, 1998, 155 (10) :1376-1383
[10]   Working in memory deficits and levels of N-acetylaspartate patients with schizophreniform disorder [J].
Bertolino, A ;
Sciota, D ;
Brudaglio, F ;
Altamura, M ;
Blasi, G ;
Bellomo, A ;
Antonucci, N ;
Callicott, JH ;
Goldberg, TE ;
Scarabino, T ;
Weinberger, DR ;
Nardini, M .
AMERICAN JOURNAL OF PSYCHIATRY, 2003, 160 (03) :483-489